Magnetar Financial’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$789K Hold
553,895
– – 0.01% 623
2026
Q2
$731K Sell
553,895
-96,105
-15% -$96.4K 0.01% 525
2026
Q1
$96.1K Hold
650,000
– – ﹤0.01% 1016
2025
Q4
$183K Hold
650,000
– – ﹤0.01% 811
2025
Q3
$188K Hold
650,000
– – ﹤0.01% 780
2025
Q2
$188K Buy
+650,000
New +$134K ﹤0.01% 806

Other funds holding TDACW

Magnetar Financial's TDACW Position: Q3 2026 in Review

Magnetar Financial held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q3 2026 at 553,895 shares worth $789K. The position accounts for 0.01% of the portfolio, ranked #623.

Magnetar Financial first reported a position in TDACW in Q2 2025 and has held it in 6 quarters since. 15 funds tracked by Wall St. Rank hold TDACW as of Q3 2026.

  • Magnetar Financial held 553,895 shares of Translational Development Acquisition Corp Warrants worth $789K as of Q3 2026.
  • Magnetar Financial left its Translational Development Acquisition Corp Warrants share count unchanged in Q3 2026.
  • Translational Development Acquisition Corp Warrants made up 0.01% of Magnetar Financial's portfolio in Q3 2026, its #623 holding.
  • Magnetar Financial first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 6 quarters since.
  • 15 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.